Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

Our results provide the basis for a detailed prospective evaluation of autoimmunity and inflammation in the context of PIDs, with a view to accurately assessing these risks and describing the possible effect of medical intervention.